Omnicell (NASDAQ: OMCL) reported Q3 EPS of $1.00, $0.05 better than the analyst estimate of $0.95. Revenue for the quarter came in at $348 million versus the consensus estimate of $363.24 million.

GUIDANCE:

Omnicell sees Q4 2022 EPS of $0.05-$0.15, versus the consensus of $1.21. Omnicell sees Q4 2022 revenue of $285-295 million, versus the consensus of $382.33 million.

Omnicell sees FY2022 EPS of $2.73-$2.83, versus the consensus of $3.84. Omnicell sees FY2022 revenue of $1.284-1.294 billion, versus the consensus of $1.4 billion.

For earnings history and earnings-related data on Omnicell (OMCL) click here.